Reference health

Trans-ethnic Mendelian-randomization study reveals causal relationships between cardiometabolic factors and chronic kidney disease

https://doi.org/10.1093/ije/dyab203
CiteStamped reference-health badge
85/85 checkable references clean · checked 2026-07-25

Every reference with a DOI in the deposited reference list resolved to a known work in Crossref or DataCite at the dated check, and none carried a retraction, withdrawal, or removal notice.

4 without a DOI — not checked. A reference deposited without a DOI is never matched by title or guessed at; it stays outside the checked set, and this line discloses that.

The 85 checked references that resolve
resolves10.1016/j.pop.2008.01.008
Chronic Kidney Disease and Its Complications
resolves10.1016/S0140-6736(16)32064-5
Chronic Kidney Disease
resolves10.1007/s11606-010-1511-x
Chronic Kidney Disease and the Risk of End-Stage Renal Disease versus Death
resolves10.1016/S0140-6736(20)30045-3
Global, regional, and national burden of chronic kidney disease, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017
resolves10.1136/bmj.k601
Reading Mendelian randomisation studies: a guide, glossary, and checklist for clinicians
resolves10.1093/ije/dyg070
‘Mendelian randomization’: can genetic epidemiology contribute to understanding environmental determinants of disease?*
resolves10.1007/s40471-017-0128-6
Recent Developments in Mendelian Randomization Studies
resolves10.1038/s41588-019-0407-x
A catalog of genetic loci associated with kidney function from analyses of a million individuals
resolves10.1371/journal.pmed.1001779
UK Biobank: An Open Access Resource for Identifying the Causes of a Wide Range of Complex Diseases of Middle and Old Age
resolves10.1016/j.je.2016.12.005
Overview of the BioBank Japan Project: Study design and profile
resolves10.1093/ije/dyr120
China Kadoorie Biobank of 0.5 million people: survey methods, baseline characteristics and long-term follow-up
resolves10.1093/ije/dyx251
MELODI: Mining Enriched Literature Objects to Derive Intermediates
resolves10.1093/bioinformatics/btaa726
MELODI Presto: a fast and agile tool to explore semantic triples derived from biomedical literature
resolves10.7326/0003-4819-150-9-200905050-00006
A New Equation to Estimate Glomerular Filtration Rate
resolves10.1017/S0033291716003172
Assessing causality in associations between cannabis use and schizophrenia risk: a two-sample Mendelian randomization study
resolves10.1681/ASN.2016010098
Mendelian Randomization as an Approach to Assess Causality Using Observational Data
resolves10.1002/sim.3034
Mendelian randomization: Using genes as instruments for making causal inferences in epidemiology
resolves10.1093/ije/dyv080
Mendelian randomization with invalid instruments: effect estimation and bias detection through Egger regression
resolves10.1093/ije/dyx102
Robust inference in summary data Mendelian randomization via the zero modal pleiotropy assumption
resolves10.1038/ijo.2010.137
C-reactive protein levels and body mass index: elucidating direction of causation through reciprocal Mendelian randomization
resolves10.1093/ije/dyt110
Power and sample size calculations for Mendelian randomization studies using one genetic instrument
resolves10.1093/ije/dyu005
Sample size and power calculations in Mendelian randomization with a single instrumental variable and a binary outcome
resolves10.7554/eLife.34408
The MR-Base platform supports systematic causal inference across the human phenome
resolves10.1038/s41467-018-07345-0
Interethnic analyses of blood pressure loci in populations of East Asian and European descent
resolves10.1371/journal.pgen.1007081
Orienting the causal relationship between imprecisely measured traits using GWAS summary data
resolves10.1093/ije/dyy101
Improving the visualization, interpretation and analysis of two-sample summary data Mendelian randomization via the Radial plot and Radial regression
resolves10.1038/ng.3245
Fine mapping of type 1 diabetes susceptibility loci and evidence for colocalization of causal variants with lymphoid gene enhancers
resolves10.1038/ncomms10023
Genetic associations at 53 loci highlight cell types and biological pathways relevant for kidney function
resolves10.1038/s41588-018-0184-y
Efficiently controlling for case-control imbalance and sample relatedness in large-scale genetic association studies
resolves10.1038/s41586-020-2263-3
Identification of type 2 diabetes loci in 433,540 East Asian individuals
resolves10.1161/CIRCGEN.117.002034
CETP (Cholesteryl Ester Transfer Protein) Concentration
resolves10.1016/S2213-8587(17)30088-8
Apolipoprotein(a) isoform size, lipoprotein(a) concentration, and coronary artery disease: a mendelian randomisation analysis
resolves10.1136/bmj.l1042
Body mass index and all cause mortality in HUNT and UK Biobank studies: linear and non-linear mendelian randomisation analyses
resolves10.1097/EDE.0000000000000161
Instrumental Variable Analysis with a Nonlinear Exposure–Outcome Relationship
resolves10.1002/gepi.22041
Semiparametric methods for estimation of a nonlinear exposure‐outcome relationship using instrumental variables with application to Mendelian randomization
resolves10.1136/bmj.322.7280.226
Sifting the evidence---what's wrong with significance tests? Another comment on the role of statistical methods
resolves10.1136/bmj.j2376
Serum uric acid levels and multiple health outcomes: umbrella review of evidence from observational studies, randomised controlled trials, and Mendelian randomisation studies
resolves10.1159/000491808
Association Between Thyroid-Stimulating Hormone and Renal Function: a Mendelian Randomization Study
resolves10.3389/fgene.2019.00415
Causal Effects of Genetically Predicted Cardiovascular Risk Factors on Chronic Kidney Disease: A Two-Sample Mendelian Randomization Study
resolves10.1016/j.jacc.2019.07.037
Impact of LDL Cholesterol on Microvascular Versus Macrovascular Disease
resolves10.1371/journal.pmed.1002725
No causal effects of serum urate levels on the risk of chronic kidney disease: A Mendelian randomization study
resolves10.1056/NEJMoa1915833
Effects of Allopurinol on the Progression of Chronic Kidney Disease
resolves10.1056/NEJMoa1916624
Serum Urate Lowering with Allopurinol and Kidney Function in Type 1 Diabetes
resolves10.7326/M14-0488
Time-Updated Systolic Blood Pressure and the Progression of Chronic Kidney Disease
resolves10.1053/j.ajkd.2019.02.015
Association Between Hypertension and Kidney Function Decline: The Atherosclerosis Risk in Communities (ARIC) Study
resolves10.1093/ajh/hpx177
Longitudinal Blood Pressure Changes and Kidney Function Decline in Persons Without Chronic Kidney Disease: Findings From the MESA Study
resolves10.1016/j.kint.2020.04.044
A bidirectional Mendelian randomization study supports causal effects of kidney function on blood pressure
resolves10.1093/ije/dyaa266
Bias in two-sample Mendelian randomization when using heritable covariable-adjusted summary associations
resolves10.1093/ndt/gfn609
Comparison of the prevalence of chronic kidney disease among different ethnicities: Beijing CKD survey and American NHANES
resolves10.1186/1471-2369-12-41
The relationship of ethnicity to the prevalence and management of hypertension and associated chronic kidney disease
resolves10.1053/j.ajkd.2019.09.003
US Renal Data System 2019 Annual Data Report: Epidemiology of Kidney Disease in the United States
resolves10.1016/j.kisu.2018.11.001
China Kidney Disease Network (CK-NET) 2015 Annual Data Report
resolves10.1016/j.kint.2016.12.013
A systematic review and meta-analysis suggests obesity predicts onset of chronic kidney disease in the general population
resolves10.1111/j.1523-1755.2004.00582.x
Body mass index and the risk of development of end-stage renal disease in a screened cohort
resolves10.7326/0003-4819-144-1-200601030-00006
Body Mass Index and Risk for End-Stage Renal Disease
resolves10.1186/s12882-019-1351-9
Joint associations of obesity and estimated GFR with clinical outcomes: a population-based cohort study
resolves10.7326/M17-2383
Microvascular Outcomes in Patients With Diabetes After Bariatric Surgery Versus Usual Care
resolves10.2215/CJN.02250409
Weight Loss Interventions in Chronic Kidney Disease
resolves10.1016/S0140-6736(06)68071-9
Kidney stones: pathophysiology and medical management
resolves10.1016/j.eururo.2012.03.052
Prevalence of Kidney Stones in the United States
resolves10.1016/j.urology.2019.04.012
Pediatric Urinary Stone Disease in the United States: The Urologic Diseases in America Project
resolves10.1097/MNH.0000000000000582
Chronic kidney disease and kidney stones
resolves10.1111/j.1523-1755.2005.67128.x
Decreased renal function among adults with a history of nephrolithiasis: A study of NHANES III
resolves10.1136/bmj.e5287
Kidney stones and kidney function loss: a cohort study
resolves10.1038/s41467-018-07867-7
Trans-ethnic kidney function association study reveals putative causal genes and effects on kidney-specific disease aetiologies
resolves10.1016/S0140-6736(13)60687-X
Chronic kidney disease: global dimension and perspectives
resolves10.1016/j.ebiom.2016.02.032
Type 2 Diabetes, Diabetes Genetic Score and Risk of Decreased Renal Function and Albuminuria: A Mendelian Randomization Study
resolves10.2337/dc19-1850
Impact of Glucose Level on Micro- and Macrovascular Disease in the General Population: A Mendelian Randomization Study
resolves10.1001/jama.2011.861
Temporal Trends in the Prevalence of Diabetic Kidney Disease in the United States
resolves10.1001/archinternmed.2011.2230
Role of Intensive Glucose Control in Development of Renal End Points in Type 2 Diabetes Mellitus
resolves10.1056/NEJMoa1811744
Canagliflozin and Renal Outcomes in Type 2 Diabetes and Nephropathy
resolves10.1161/CIRCULATIONAHA.119.044359
Evaluating the Effects of Canagliflozin on Cardiovascular and Renal Events in Patients With Type 2 Diabetes Mellitus and Chronic Kidney Disease According to Baseline HbA1c, Including Those With HbA1c <7%
resolves10.3390/toxins8120376
Modified Lipids and Lipoproteins in Chronic Kidney Disease: A New Class of Uremic Toxins
resolves10.1053/j.ajkd.2017.06.011
HDL Cholesterol, LDL Cholesterol, and Triglycerides as Risk Factors for CKD: A Mendelian Randomization Study
resolves10.1016/j.atherosclerosis.2020.03.020
Association of blood lipid profile with incident chronic kidney disease: A Mendelian randomization study
resolves10.1016/j.jacc.2016.10.033
Phenotypic Characterization of Genetically Lowered Human Lipoprotein(a) Levels
resolves10.1053/j.ajkd.2017.10.006
Challenges in Interpreting Multivariable Mendelian Randomization: Might “Good Cholesterol” Be Good After All?
resolves10.1056/NEJMoa1706444
Effects of Anacetrapib in Patients with Atherosclerotic Vascular Disease
resolves10.1371/journal.pone.0114397
Plasma Lipoprotein(a) Levels Are Associated with Mild Renal Impairment in Type 2 Diabetics Independent of Albuminuria
resolves10.1681/ASN.V111105
Lipoprotein(a) Serum Concentrations and Apolipoprotein(a) Phenotypes in Mild and Moderate Renal Failure
resolves10.1053/ajkd.2002.36319
Association of kidney function with serum lipoprotein(a) level: The Third National Health and Nutrition Examination Survey (1991-1994)
resolves10.1016/S0140-6736(15)61252-1
Antisense therapy targeting apolipoprotein(a): a randomised, double-blind, placebo-controlled phase 1 study
resolves10.1053/j.ajkd.2014.01.012
Awareness of CKD in China: A National Cross-sectional Survey
resolves10.1681/ASN.2004070539
Chronic Kidney Disease Awareness, Prevalence, and Trends among U.S. Adults, 1999 to 2000
resolves10.1093/ije/dyx206
Collider scope: when selection bias can substantially influence observed associations
The 4 references without a DOI — listed, not checked
no DOI — not checkedThe Nord-Trøndelag Health Study 1995-97 (HUNT 2)
no DOI — not checkedAssessing the suitability of summary data for two-sample Mendelian randomization analyses using MR-Egger regression: the role of the I 2 statistic
no DOI — not checkedDetecting individual and global horizontal pleiotropy in Mendelian randomization: a job for the humble heterogeneity statistic?
no DOI — not checkedLipid disorders in patients with renal failure: role in cardiovascular events and progression of chronic kidney disease
What this badge says. CiteStamped means the CHECKABLE references of this work were clean at the dated check: each resolved to a known work in a public registry, and none carried a retraction notice at that time. It says nothing about the quality, findings, or importance of the work itself, and nothing about references deposited without a DOI.

checked 2026-07-25 — re-checked daily as this page is visited; titles and statuses come from Crossref and DataCite and are not part of the signed record

Embed this badge

Both snippets point at the live badge image and link back to this page. The badge re-renders from the daily check, so an embed never goes stale by more than a day of visits.

<a href="https://citestamp.com/citestamped/10.1093/ije/dyab203"><img src="https://citestamp.com/citestamped/10.1093/ije/dyab203/badge.svg" alt="CiteStamped reference-health badge" width="460" height="64"></a>
[![CiteStamped reference-health badge](https://citestamp.com/citestamped/10.1093/ije/dyab203/badge.svg)](https://citestamp.com/citestamped/10.1093/ije/dyab203)